Skip to main content
. 2012 Mar;10(1):12–48. doi: 10.2174/157015912799362805

Table 4.

Summary of Preclinical Studies Supporting a Role of mGluRs in Major Depression Disorder and Anxiety

Receptor Subtype Pharmacological Tool Effect References
Group I
mGluR1 JNJ16259685 (antagonist) ↓ Anxiety-like behaviour in the rat lick suppression test Steckler et al. 2005
AIDA (antagonist) ↓ Anxiogenic behaviour in the rat light-dark test and open-field test Mikulecka and Mares 2009
mGluR5 MPEP (antagonist) ↓ Anxiogenic behaviour in elevated-plus maze, social exploration, fear-potentiated startle, Vogel-conflict and light-dark box test Ballard et al. 2005; Spooren et al. 2000; Spooren and Gasparini 2004; Tatarczynska et al. 2001; Mikulecka and Mares 2009; Spanka et al. 2010
MTEP (antagonist) ↓ Anxiogenic behaviour contextual fear conditioning Gravius et al. 2008
MPEP & MTEP (antagonists) ↓ Immobility time in the tail-suspension test and forced-swim test Tatarczynska et al. 2001; Palucha et al. 2005; Belozertseva et al. 2007; Li et al. 2006
Antidepressant-like effects in the olfactory bulbectomy model Palucha et al. 2005;Pilc et al. 2002
Group II
mGluR2/3 LY341495 (antagonist) ↑ Firing rate of serotonergic dorsal raphe neurones Kawashima et al. 2005
MGS0039 (antagonist) ↑ Firing rate of serotonergic dorsal raphe neurones Kawashima et al. 2005
↑ Extracellular levels of serotonin in the rat prefrontal cortex Karasawa et al. 2005
LY341495 & MGS0039 (antagonists) ↓ Immobility and in the tail-suspension test and forced-swim test Witkin et al. 2007; Chaki et al. 2004
LY341495 (antagonist) Effective in the marble burying test ↔ Anxiogenic behaviour in elevated plus maze and stress-induced hyperthermia tests Bespalov et al. 2008
MGS0039 (antagonist) ↓ Anxiogenic behaviour in the conditioned fear model Yoshimizu et al. 2006
Group III
ACPT-I (agonist) ↓ Immobility time in the forced-swim test Tatarczynska et al. 2002; Palucha et al. 2004c; Klak et al. 2007
↓ Anxiogenic behaviour in the stress-induced hyperthermia, elevated plus-maze tests and in the Vogel test Stachowicz et al. 2009
mGluR4 PHCCC (PAM) ↓ Immobility time in the forced-swim test Klak et al. 2007
mGluR7 AMN082 (agonist) ↓ Immobility time in the forced swim test and tail suspension test Palucha et al. 2007
mGluR8 RSPPG (agonist) ↓ Immobility time in the forced-swim test Palucha et al. 2004b

Abbreviations and symbols: ↔, unchanged; ↑, increased; ↓, decreased; PAM, positive allosteric modulator.

HHS Vulnerability Disclosure